Senior Lecturer in Health Economics
Newcastle Business School, University of Newcastle, Australia
Behavioural Health Economist | Patient Preferences & Choice Modelling Expert
Dr. Mesfin Genie is a distinguished Senior Lecturer in Health Economics at Newcastle Business School, University of Newcastle, Australia. With expertise spanning health economics, discrete choice experiments (DCE), patient preferences, and behavioral economics in healthcare, Dr. Genie's research addresses critical areas such as organ donation, vaccine hesitancy, telemedicine adoption, and the economics of chronic diseases like diabetes, cancer, and dementia.
His extensive international background includes academic and research positions in Ethiopia, Italy, the UK, USA, and Australia. Dr. Genie earned his PhD in Economics from Ca' Foscari University of Venice, bringing a global perspective to his impactful work in understanding and shaping health policy.
Exploring how individuals value health outcomes and interventions, influencing policy and treatment decisions.
Using innovative methods to understand cognitive processes behind health-related choices.
Developing and applying robust methods to quantify health benefits and quality of life.
Analysing and advocating for fair distribution of healthcare resources and access.
Investigating behavioral factors influencing vaccine uptake and responses to public health crises.
Applying psychological insights to economic models to better understand health behaviors.
Newcastle Business School, University of Newcastle, Australia (Current)
Auburn University, USA
University of Aberdeen, UK
Ca' Foscari University of Venice, Italy
Duke University, USA
Ca' Foscari University of Venice, Italy
University of Bologna, Italy
Addis Ababa University, Ethiopia
Jimma University, Ethiopia
Dr. Mesfin Genie's work is published in leading academic journals including the Journal of Health Economics, Health Economics, Social Science & Medicine, and Value in Health. His research, cited over 900 times on Google Scholar, significantly contributes to the understanding of patient preferences in kidney transplantation and pandemic trade-offs.
Feel free to reach out for collaborations, inquiries, or academic discussions.
Email Mesfin Genie